|
Dasatinib
Theoretical analysis:Dasatinib
Molecular Formula: C22H28ClN7O3S
Formula Weight: 506.02082
CAS No.: 863127-77-9
A...
更多>>
|
|
|
GSK1838705A
Description of:GSK1838705A
GSK1838705A prevents the in vitro proliferation of cell lines derived from solid and hematologic malignancies, inclu...
更多>>
|
|
|
ASP 3026
Description of:ASP 3026
ASP-3026 is an ALK inhibitor in clinical trials
Theoretical analysis:ASP 3026
Molecul...
更多>>
|
|
|
AST-6
Description of:AST-6
AST-6, a rationally designed novel anilino-quinazoline compound, inhibited enzymatic activities of wild type EGFR and ErbB...
更多>>
|
|
|
TAK 285
Description of:TAK 285
TAK-285 is currently under clinical development. TAK-285 may have a unique role in the treatment of brain lesions ...
更多>>
|
|
|
Bafetinib(INNO-406)
Description of:Bafetinib(INNO-406)
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor that is up to 55-times more poten...
更多>>
|
|
|
CP-547632
Theoretical analysis:CP-547632
MF:C20H24BrF2N5O3S
MW:532.408
CAS:252003-65-9
Availability and price:CP-547632更多>>
|
|
|
AZD4547
Description of:AZD4547
FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal trans...
更多>>
|
|
|
Imatinib Mesylate
Description of:Imatinib Mesylate
Inhibition of CSF-1R by imatinib is competitive with ATP, with a Ki value of 120 nM. Imatinib also stimulates ...
更多>>
|
|
|
LDN193189
Description of:LDN193189
A highly potent small molecule BMP inhibitor; inhibiting BMP type I receptors ALK2 (IC50: 5 nM), ALK3 (IC50: 30 nM) an...
更多>>
|
|